Cover Image

Haploidentical CD7 CAR T-cells induced remission in a patient with TP53 mutated relapsed and refractory early T-cell precursor lymphoblastic leukemia/lymphoma

Abstract Patients with relapsed/refractory early T-cell precursor lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) respond poorly to traditional therapy and have dismal prognosis. CD7 is a promising therapeutic targets for chimeric antigen receptor modified T cell therapy (CART) due to its widely expre...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hai-ping Dai (Author), Wei Cui (Author), Qing-ya Cui (Author), Wen-juan Zhu (Author), Hui-min Meng (Author), Min-qing Zhu (Author), Xia-ming Zhu (Author), Lin Yang (Author), De-pei Wu (Author), Xiao-wen Tang (Author)
Format:	Book
Published:	BMC, 2022-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effectiveness of T-Cell Replete Haploidentical Hematopoietic Stem Cell Transplantation for Refractory/Relapsed B Cell Acute Lymphoblastic Leukemia in Children and Adolescents
by: Hideki Sano, et al.
Published: (2021)

CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia
by: Vairy S, et al.
Published: (2018)

Short-course blinatumomab for refractory/relapse precursor B acute lymphoblastic leukemia in children
by: Jiao Xie, et al.
Published: (2023)

Aberrant TP53 pathways regulate leukaemic cell survival in acute lymphoblastic leukaemia
by: Pritha Paul, et al.
Published: (2017)

Inotuzumab ozogamicin: a CD22 mAb–drug conjugate for adult relapsed or refractory B-cell precursor acute lymphoblastic leukemia
by: Yurkiewicz IR, et al.
Published: (2018)

Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report
by: Meng-Yun Li, et al.
Published: (2020)

Use of blinatumomab and CAR T-cell therapy in children with relapsed/refractory leukemia: A case series study
by: Songmi Wang, et al.
Published: (2023)

Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis
by: Guillaume Morelle, et al.
Published: (2021)

The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL
by: Forsberg MH, et al.
Published: (2018)

dic(7;9) with loss of Tp53 gene in acute lymphoblastic leukemia
by: Anurag Gupta, et al.
Published: (2016)

Cytokine Release Syndrome Is an Independent Risk Factor Associated With Platelet Transfusion Refractoriness After CAR-T Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia
by: Yadan Liu, et al.
Published: (2021)

A case of B-cell lymphoblastic leukemia cutis flaring following CAR T-cell therapy in a patient with refractory acute lymphoblastic leukemia
by: Pranav Puri, BA, et al.
Published: (2021)

Precursor B-cell acute lymphoblastic leukemia presenting with isolated skin relapse: a pediatric case report
by: Yeter Düzenli Kar, et al.
Published: (2023)

Efficacy and Safety of CAR-Modified T Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Prospective Clinical Trials
by: Xinrong Xiang, et al.
Published: (2020)

Effects of CAR-T Cell Therapy on Immune Cells and Related Toxic Side Effect Analysis in Patients with Refractory Acute Lymphoblastic Leukemia
by: Lianlian Li, et al.
Published: (2023)

Co-mutations of TP53 and KRAS serve as potential biomarkers for immune checkpoint blockade in squamous-cell non-small cell lung cancer: a case report
by: Cheng Fang, et al.
Published: (2019)

First-in-class transactivator-free, doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B cell lymphomas
by: Pedro Justicia-Lirio, et al.
Published: (2024)

Isolated Breast Relapse of Early T-Cell Precursor Acute Lymphoblastic Leukemia after Stem Cell Transplantation: A Pediatric Case and Literature Review
by: Bo Ram Kim, et al.
Published: (2022)

Effect of TP53 rs1042522 on the susceptibility of patients to oral squamous cell carcinoma and oral leukoplakia: a meta-analysis
by: Zhen Sun, et al.
Published: (2018)

Creation and preliminary characterization of a Tp53 knockout rat
by: Aaron McCoy, et al.
Published: (2013)

Successful hematopoietic stem cell transplantation for two patients with relapse of intrachromosomal amplification of chromosome 21-positive B-cell precursor acute lymphoblastic leukemia
by: Tomoya Harada, et al.
Published: (2022)

Novel Treatments for Pediatric Relapsed or Refractory Acute B-Cell Lineage Lymphoblastic Leukemia: Precision Medicine Era
by: Shang Mengxuan, et al.
Published: (2022)

Rituximab monotherapy in precursor-B-Cell acute Lymphoblastic leukaemia: Managing relapse or graft rejection post-allogenic bone marrow transplant
by: Rachit Khandelwal, et al.
Published: (2024)

TP53 loss initiates chromosomal instability in fallopian tube epithelial cells
by: Daniel Bronder, et al.
Published: (2021)

Haploidentical vs. HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Bone Marrow Transplantation in Children (GETMON/GETH) and the Spanish Childhood Relapsed ALL Board (ReALLNet)
by: Celia Moreno, et al.
Published: (2023)

T-Cell-Replete Versus ex vivo T-Cell-Depleted Haploidentical Haematopoietic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukaemia and Other Haematological Malignancies
by: Katharina Kleinschmidt, et al.
Published: (2021)

Clinical aspects of TP53 gene inactivation in diffuse large B-cell lymphoma
by: Elena N. Voropaeva, et al.
Published: (2019)

HLA-Haploidentical Family Donors: The New Promise for Childhood Acute Lymphoblastic Leukaemia?
by: Syaza Ab Rahman, et al.
Published: (2022)

The Immunobiology of HLA-Haploidentical Hematopoietic Cell Transplantation
Published: (2020)

T cell depleted haploidentical transplantation: positive selection
by: Franco Aversa
Published: (2011)

Treatment strategies for relapse after CAR T-cell therapy in B cell lymphoma
by: Shuto Negishi, et al.
Published: (2024)

Efficacy and safety of blinatumomab in children with relapsed/refractory B cell acute lymphoblastic leukemia: A systematic review and meta-analysis
by: Bin Chen, et al.
Published: (2023)

Cost-Effectiveness Analysis of Tisagenlecleucel in the Treatment of Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia in Children and Young Adults in Spain
by: Ribera Santasusana JM, et al.
Published: (2020)

T-cell depleted haploidentical hematopoietic cell transplantation for pediatric malignancy
by: Takuto Takahashi, et al.
Published: (2022)

Inside the biology of early T-cell precursor acute lymphoblastic leukemia: the perfect trick
by: Francesco Tarantini, et al.
Published: (2021)

New genetics and diagnosis of childhood B-cell precursor acute lymphoblastic leukemia
by: Christine Harrison
Published: (2011)

Precursor B- cell lymphoblastic lymphoma/leukaemia masquerading as epidermal cyst of scalp
by: Basab Bagchi, et al.
Published: (2020)

Somatic intronic TP53 c.375+5G mutations are a recurrent but under‐recognized mode of TP53 inactivation
by: M Herman Chui, et al.
Published: (2022)

First Successful Haploidentical Stem Cell Transplantation in Romania
by: Tănase Alina, et al.
Published: (2016)

Induction of pancreatic neoplasia in the KRAS/TP53 Oncopig
by: Pinaki Mondal, et al.
Published: (2023)